Loading clinical trials...
Loading clinical trials...
This study investigates the association between post-reperfusion (neohepatic) ALBI scores and post-LT renal outcomes in living-donor LT (LDLT) recipients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Asan Medical Center
NCT06517810 · Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
NCT05349292 · Acute Kidney Injury
NCT06772025 · Cardiac Surgery-associated Acute Kidney Injury
NCT06446739 · Acute Kidney Injury, Dialysis; Complications
NCT07490808 · Atrial Fibrillation (AF), Acute Kidney Injury
Asan Medical Center
Seoul, Song-pa Gu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions